Miracor Medical
Miracor Medical is focused on clinically effective technology that aims to significantly improve the lives of patients suffering from cardiac disease. The company develops innovative medical devices, including the PiCSO Pressure-controlled intermittent Coronary Sinus Occlusion system, to reduce infarct size and improve microcirculatory function during acute myocardial infarction treatments. Miracor's mission is to enhance patient outcomes through advanced therapies and to support the development and adoption of their innovative solutions in the cardiovascular field.
Industries
Nr. of Employees
small (1-50)
Miracor Medical
174 rue de Bruxelles, E40 Business Park, 4340 Awans, Belgium
Products
Integrated coronary sinus occlusion interventional system (balloon catheter + procedure console)
An interventional system composed of a transvenous coronary sinus balloon catheter and a procedure console that monitors coronary sinus pressure and controls automated inflation/deflation cycles to improve microvascular perfusion during PCI.
Integrated coronary sinus occlusion interventional system (balloon catheter + procedure console)
An interventional system composed of a transvenous coronary sinus balloon catheter and a procedure console that monitors coronary sinus pressure and controls automated inflation/deflation cycles to improve microvascular perfusion during PCI.
Services
Design and operational management of pivotal and randomized clinical studies for interventional cardiac devices, including site selection, imaging endpoints and longitudinal follow-up.
Establishing regional distribution agreements, structured tender management and reimbursement strategy support to enable market introduction.
Clinical training programs and targeted support to qualified centers to enable procedural adoption and safe use of an interventional therapy.
Design and operational management of pivotal and randomized clinical studies for interventional cardiac devices, including site selection, imaging endpoints and longitudinal follow-up.
Establishing regional distribution agreements, structured tender management and reimbursement strategy support to enable market introduction.
Clinical training programs and targeted support to qualified centers to enable procedural adoption and safe use of an interventional therapy.
Expertise Areas
- Interventional cardiology device development
- Clinical trial management for cardiovascular devices
- Regulatory strategy and submissions for medical devices (CE Mark, FDA IDE)
- Catheter and balloon-based system engineering
Key Technologies
- Transvenous coronary sinus balloon catheter systems
- Pressure-controlled intermittent coronary sinus occlusion (therapeutic approach)
- Embedded procedural monitoring and automated control algorithms
- Cardiac magnetic resonance imaging for infarct quantification
News & Updates
Miracor Medical announced FDA IDE approval for a pivotal study evaluating the safety and efficacy of PiCSO in acute anterior STEMI patients.
The company has initiated a second randomized study to evaluate PiCSO in broader patient populations.
Miracor Medical successfully raised 24 million euros in funding.
Miracor Medical received CE Mark approval for its PiCSO Impulse Catheter and Console, enabling commercialization in Europe.
Miracor Medical announced FDA IDE approval for a pivotal study evaluating the safety and efficacy of PiCSO in acute anterior STEMI patients.
The company has initiated a second randomized study to evaluate PiCSO in broader patient populations.
Miracor Medical successfully raised 24 million euros in funding.
Miracor Medical received CE Mark approval for its PiCSO Impulse Catheter and Console, enabling commercialization in Europe.